{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:59:49Z","timestamp":1773370789698,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":3288,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/sj.jid.5700465","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T00:20:58Z","timestamp":1151626858000},"page":"2631-2636","source":"Crossref","is-referenced-by-count":72,"title":["Antigen Specificity in Subsets of Mucous Membrane Pemphigoid"],"prefix":"10.1016","volume":"126","author":[{"given":"Khwaja A.","family":"Rashid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan M.","family":"G\u00fcrcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Razzaque Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.jid.5700465_bb0010","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1038\/sj.jid.5700465_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1601-0825.2005.01140.x","article-title":"Mucosal disease series. Number III. Mucous membrane pemphigoid","volume":"11","author":"Bagan","year":"2005","journal-title":"Oral Dis"},{"key":"10.1038\/sj.jid.5700465_bb0020","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1177\/00220345010800080601","article-title":"Autoantibodies to human alpha6 integrin in patients with oral pemphigoid","volume":"80","author":"Bhol","year":"2001","journal-title":"J Den Res"},{"key":"10.1038\/sj.jid.5700465_bb0025","first-page":"2283","article-title":"The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid","volume":"40","author":"Chan","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/sj.jid.5700465_bb0030","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1172\/JCI116033","article-title":"Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease","volume":"90","author":"Domloge-Hultsch","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.jid.5700465_bb0035","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/S0140-6736(00)04971-0","article-title":"Anti-epiligrin cicatricial pemphigoid and relative risk for cancer","volume":"357","author":"Egan","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/sj.jid.5700465_bb0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.md.0000076003.64510.00","article-title":"Anti epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations","volume":"82","author":"Egan","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1038\/sj.jid.5700465_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1034\/j.1600-0625.2000.009004271.x","article-title":"Bovine gingival lysate: a novel substrate for rapid diagnosis of autoimmune vesiculobullous disease. A preliminary observation","volume":"9","author":"Engineer","year":"2000","journal-title":"Exp Dermatol"},{"key":"10.1038\/sj.jid.5700465_bb0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/sj.jid.5700465_bb0055","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1038\/sj.jid.5700465_bb0060","first-page":"379","article-title":"Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin","volume":"42","author":"Kumari","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/sj.jid.5700465_bb0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1056\/NEJMoa011979","article-title":"The prevalence of proteolytic antibodies against factor VIII in hemophilia A","volume":"346","author":"Lacroix-Desmazes","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.jid.5700465_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/clim.2001.5091","article-title":"IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit","volume":"101","author":"Lazarova","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1038\/sj.jid.5700465_bb0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1076\/0271-3683(200008)2121-VFT646","article-title":"Influence of intravenous immunoglobulin therapy on serum levels of anti-beta4 antibodies in ocular cicatricial pemphigoid","volume":"21","author":"Letko","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1038\/sj.jid.5700465_bb0080","first-page":"2713","article-title":"Ocular cicatricial pemphigoid and relative risk for cancer","volume":"45","author":"Letko","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1038\/sj.jid.5700465_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(01)00863-6","article-title":"The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1038\/sj.jid.5700465_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1079-2104(98)90395-X","article-title":"Oral pemphigoid. Subset of cicatricial pemphigoid?","volume":"85","author":"Mobini","year":"1998","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1038\/sj.jid.5700465_bb0095","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.4049\/jimmunol.176.3.1968","article-title":"Identification of an epitope within human integrin \u03b16 subunit for the binding of autoantibody and its role in basement membrane separation in oral pemphigoid","volume":"176","author":"Rashid","year":"2006","journal-title":"J of Immunol"},{"key":"10.1038\/sj.jid.5700465_bb0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1046\/j.1365-2249.2002.01942.x","article-title":"Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titre to human alpha6 integrin","volume":"129","author":"Sami","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1038\/sj.jid.5700465_bb0105","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2004.04.010","article-title":"Profile of autoantibody to basement membrane zone proteins in patients with mucous membrane pemphigoid: long-term follow up and influence of therapy","volume":"112","author":"Yeh","year":"2004","journal-title":"Clin Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15327226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15327226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T17:50:03Z","timestamp":1555696203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15327226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0022202X15327226"],"URL":"https:\/\/doi.org\/10.1038\/sj.jid.5700465","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}